Recent Updates
Recently added Catalysts
PHGE Positive Sentiment

BiomX to Present at the 2024 RBC Capital Markets Global Healthcare Conference

Monday, May 6, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: BiomX Inc. will participate in the RBC Capital Markets Global Healthcare Conference scheduled for May 15, 2024, in New York City. Chief Business Officer Assaf Oron will present the company’s innovative approaches to phage therapies targeting specific pathogenic bacteria. Attendees can access a live webcast of the presentation, which will be archived for future reference. This involvement signals BiomX's efforts to increase investor awareness and engagement.
Price reaction · baseline $72.941 (2024-05-03 close) · clean, no other PHGE news in the window
day 0 close
+6.3%
day 1
+4.2%
day 3
-6.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • BiomX is presenting at a reputable conference, raising visibility.
  • The presentation format includes one-on-one meetings, allowing for direct engagement with investors.
  • The company focuses on innovative phage therapies, highlighting their commitment to addressing chronic diseases.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+190%
120-day peak, hindsight
Typical move
13.4%
average across 4 past catalysts
Cash runway
~1 mo
High dilution risk
Lead asset
BX002-A
Phase 1 · Healthy Volunteers

Full Press Release Details

CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 06, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced the company will participate in the RBC Capital Markets Global Healthcare Conference in New York City on Wednesday, May 15, 2024.
Date & Time: Wednesday, May 15, 4:05 PM ET
Format: Presentation and one-on-one meetings
Presenter: Assaf Oron, Chief Business Officer
The live webcast of the presentation will be accessible through the Investors section of the Company’s website at https://ir.biomx.com/news-events/ir-calendar. The webcast also will be archived on the BiomX website for a period of 3 months.
BiomX is a clinical-stage company developing both natural and engineered phage cocktails and personalized phage treatments designed to target and destroy bacteria in the treatment of chronic diseases. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets. For more information, please visit www.biomx.com, the content of which does not form a part of this press release.

Frequently Asked Questions

When will BiomX participate in the RBC Healthcare Conference?

BiomX will participate in the RBC Capital Markets Healthcare Conference on May 15, 2024.

Who is presenting for BiomX at the conference?

Assaf Oron, the Chief Business Officer, will present for BiomX.

Where can I watch the BiomX presentation live?

The live webcast of the presentation will be available on the BiomX Investors section.

What does BiomX specialize in?

BiomX specializes in developing phage therapies targeting specific pathogenic bacteria.

How long will the webcast be archived on BiomX's site?

The webcast will be archived for a period of 3 months on BiomX's website.

ShareAdd on Google
Tags: PHGE Viatris Investor Conferences Healthcare BiomX RBC Capital Markets phage therapies chronic diseases pharmaceutical
Last updated: May 6, 2024

Biotech snapshot

Cash runway
$1M liquidity · $0M/mo burn
~1 mo
High dilution risk
Lead asset
BX002-APhase 1
Healthy Volunteers →

Catalyst track record

+190%
best trade around PHGE's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for PHGE.

See every catalyst's timing & PoA →